Skip to content

Global Epigenetics Market (2022 to 2027) – Use of Epigenetics in Non-Oncology Applications Presents Opportunities – Yahoo Finance

DUBLIN, Aug. 29, 2022 /PRNewswire/ — The “Epigenetics Market by Product & Service (Enzymes (DNA-modifying Enzymes), Kits & Reagents (Antibodies), Software, Service), Method (DNA Methylation), Technique (NGS, PCR & qPCR), Application (Oncology, Immunology), End User – Global Forecast to 2027” report has been added to ResearchAndMarkets.com’s offering. 
The global epigenetics market is projected to reach USD 3.9 Billion by 2027 from USD 1.7 Billion in 2022, at a CAGR of 18.1% during the forecast period.
The kits & reagents segment dominates the epigenetics market through the study period of 2020-2027.
Based on product & service, the global epigenetics market is segmented into kits & reagents, enzymes, instruments and accessories, software, and service. The dominance of kits & reagents segment is attributed to affordable and convenient kits introduced by the market participants.
This is expected to suffice the significant elevation in the number of epigenetics research activities conducted in the past few years. Additionally, market players are expanding their product offerings around epigenetics antibodies, which is further expected to supplement the segment’s dominance.
The histone modifications segment will witness the highest growth in the epigenetics market during the forecast period.
Based on method, the global epigenetics market is segmented into DNA methylation, histone modifications, and other methods. Histone modifications include different approaches such as, methylation, citrullination, ubiquitination, acetylation, and phosphorylation.
Additionally, research professionals are focusing on understanding the potential of histone modifications in oncology which is expected to promote the segment growth through 2022 to 2027.
North America dominated the epigenetics market in 2021.
Geographically, the epigenetics market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. In 2021, North America accounted for the largest share of the epigenetics market. North America harbors majority of the key market players leading to maturity of epigenetics market in this region.
Also, robust government support for academic & research activities offer opportunity for the key market players to introduce cutting-edge epigenetics products, further intensifying regional market competition.
Key Topics Covered:
1 Introduction
2 Research Methodology
3 Executive Summary
4 Premium Insights
4.1 Epigenetics Market Overview
4.2 North America: Market Share, by Product & Service and Country (2021)
4.3 North America: Market, by Method, 2021 vs. 2027 (USD Million)
5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Epigenetic Enzymes Gaining Traction in Drug Discovery & Development
5.2.1.2 Rising Investments, Funds, and Grants for Epigenetics Research
5.2.1.3 Declining Costs of Genome Sequencing
5.2.2 Restraints
5.2.2.1 Limited Applications of Epigenomic Data in Toxicology
5.2.3 Opportunities
5.2.3.1 Use of Epigenetics in Non-Oncology Applications
5.2.4 Challenges
5.2.4.1 Challenges Associated with Epigenetic Editing
5.2.4.1.1 Off-Target Effect
5.2.4.1.2 Other Challenges
5.3 Scenarios Arising Out of Uncertainties Affecting Market Growth
5.4 Impact of COVID-19 on the Epigenetics Market
5.5 Porter’s Five Forces Analysis
5.6 Ecosystem Analysis
5.7 Value Chain Analysis
5.8 Supply Chain Analysis
5.9 Regulatory Analysis
6 Epigenetics Market, by Product & Service
6.1 Introduction
6.2 Kits & Reagents
6.2.1 Antibodies
6.2.1.1 Increasing Demand for Recombinant Antibodies for the Detection of Epigenetic Targets Propels the Segment Growth
6.2.2 Chip-Sequencing Kits & Reagents
6.2.2.1 Versatile Applications of Chip in Epigenetic Regulatory Systems Contribute to the Segment’s Dominant Share
6.2.3 Bisulfite Conversion Kits & Reagents
6.2.3.1 Effectiveness of Bisulfite Conversion in Gene-Specific and Genome-Wide Analyses to Drive the Demand for Kits & Reagents
6.2.4 Whole-Genome Amplification Kits & Reagents
6.2.4.1 Whole-Genome Amplification Maintains the Relative Proportions of Genes Present in the Original Pool, Increasing Its Preference Among Researchers
6.2.5 5-Hmc & 5-Mc Analysis Kits & Reagents
6.2.5.1 Introduction of Unique Kits Drives Market Growth
6.2.6 Histones
6.2.6.1 Importance of Chromatin-Associated Proteins & Histones in Epigenetic Research to Drive the Segment Growth
6.2.7 Other Kits & Reagents
6.3 Enzymes
6.3.1 DNA-Modifying Enzymes
6.3.1.1 Growing Applications of DNA Methylation to Contribute to the Segment’s Dominant Share
6.3.2 Protein-Modifying Enzymes
6.3.2.1 Increasing Pipeline of Epigenetics-based Drugs Targeting Histone-Modifying Enzymes to Drive the Segment Growth
6.3.3 Other Enzymes
6.4 Instruments & Accessories
6.4.1 Wide Usage of Ngs Instruments and Sonicators to Contribute to the Segment Revenue
6.5 Software
6.5.1 Development of Viable Software Solutions for DNA Methylation, Chromatin, and RNA Analysis to Propel Segment Growth
6.6 Services
6.6.1 Expanding Pool of Providers to Drive the Services Segment
7 Epigenetics Market, by Method
7.1 Introduction
7.2 DNA Methylation
7.2.1 DNA Methylation to Dominate the Methods Market Till 2027
7.3 Histone Modifications
7.3.1 Technological Advancements to Drive Segment Growth
7.4 Other Methods
8 Epigenetics Market, by Technique
8.1 Introduction
8.2 Ngs
8.2.1 Ngs Offers Comprehensive Epigenetic Profiles, Which Drives Adoption
8.3 Pcr & qPCR
8.3.1 Rising Number of Pcr-based Epigenetics Service Providers to Propel the Segment Growth
8.4 Mass Spectrometry
8.4.1 Growing Demand for Mass Spectrometry in Histone Epigenetics Studies to Drive the Segment Growth
8.5 Sonication
8.5.1 Advent of Improved High-Throughput Sonication to Propel Its Adoption in Epigenetics Studies
8.6 Other Techniques
9 Epigenetics Market, by Application
9.1 Introduction
9.2 Oncology
9.2.1 Oncology to Hold Largest Share of the Applications Segment Till 2027
9.3 Metabolic Diseases
9.3.1 Emerging Role of DNA Methylation in Diabetes Management to Drive the Segment Growth
9.4 Immunology
9.4.1 Rising Demand for Epigenetics Products in Tumor and Transplantation Immunology to Drive Segment’s Growth
9.5 Developmental Biology
9.5.1 Growing R&D in Developmental Biology to Propel the Segment’s Growth
9.6 Cardiovascular Diseases
9.6.1 Emerging Role of Epigenetics in Understanding the Etiology of Cardiovascular Diseases to Propel Product Adoption
9.7 Other Applications
10 Epigenetics Market, by End-user
10.1 Introduction
10.2 Academic & Research Institutes
10.2.1 High Share Attributed to Rising Collaborations Among Research Institutes and Demand for Cancer Epigenetics
10.3 Pharmaceutical & Biotechnology Companies
10.3.1 High Number of Clinical Trials for Epigenetics-based Drugs to Drive the Segment Growth
10.4 Hospitals & Clinics
10.4.1 Rising Importance of DNA Methylation Measurements to Drive Segment Growth
11 Epigenetics Market, by Region
12 Competitive Landscape
12.1 Introduction
12.2 Right-To-Win Approaches Adopted by Key Players
12.3 Market Share Analysis
12.4 Revenue Share Analysis (Top 5 Market Players)
12.5 Company Evaluation Quadrant (Key Market Players)
12.5.1 Stars
12.5.2 Emerging Leaders
12.5.3 Pervasive Players
12.5.4 Participants
12.5.5 Competitive Benchmarking – Startups/SMEs
12.6 Competitive Scenario and Trends
12.6.1 Product Launches
12.6.2 Deals
13 Company Profiles
13.1 Key Companies
13.1.1 Thermo Fisher Scientific Inc.
13.1.2 Illumina, Inc.
13.1.3 Pacific Biosciences
13.1.4 Abcam PLC.
13.1.5 Merck KGaA
13.1.6 Bio-Rad Laboratories, Inc.
13.1.7 Active Motif
13.1.8 New England Biolabs
13.1.9 Qiagen
13.1.10 Zymo Research Corporation
13.1.11 Perkinelmer Inc.
13.1.12 Diagenode
13.1.13 F. Hoffmann-La Roche Ltd.
13.1.14 Promega Corporation
13.2 Other Players
13.2.1 Epigentek Group Inc.
13.2.2 Epicypher
13.2.3 Everon Life Sciences
13.2.4 Fios Genomics
13.2.5 Genomescan
13.2.6 Creative Biogene
14 Appendix
For more information about this report visit https://www.researchandmarkets.com/r/8hup6o
Media Contact:
Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1904
Fax (outside U.S.): +353-1-481-1716
Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
View original content:https://www.prnewswire.com/news-releases/global-epigenetics-market-2022-to-2027—use-of-epigenetics-in-non-oncology-applications-presents-opportunities-301613821.html
SOURCE Research and Markets
In this article, we discuss 10 undervalued stock picks from Warren Buffett’s latest portfolio. You can skip our discussion on Buffett’s recent investment decisions and go directly to Warren Buffett’s Latest Portfolio: 5 Undervalued Stock Picks. Warren Buffett will turn 92 years old on August 30, and the billionaire is showing no signs of a […]
Uranium is blowing higher Monday. All the miners are up: Cameco Corp , Uranium Energy Corp. , and Denison Mines . But we could see more upside here. DNN was over $2.00 at one point in 2021, and it appears the European push to keep Nuclear power going could be a nice catalyst for these names.
In this article, we discuss the 10 best stocks to buy now according to billionaire Ken Fisher. If you want to skip the investment philosophy of Ken Fisher and the detailed analysis of Fisher Asset Management, go directly to the 5 Best Stocks to Buy Now According to Billionaire Ken Fisher. Ken Fisher is an […]
In this article, we discuss 10 cash-rich defensive stocks to buy before recession. If you want to read about some more cash-rich defensive stocks to buy before recession, go directly to 5 Cash-Rich Defensive Stocks to Buy Before Recession. The average savings of daily Americans are drying up as the United States economy slows down. […]
Moscow is raking in more revenue than ever with the help of new buyers, new traders and the world’s seemingly insatiable demand for crude. “Nobody’s brave enough to embargo 7.5 million barrels a day of Russian oil and oil products.”
Stocks started slipping recently as investors grasped that the Fed likely won't soon reverse interest-rate hikes.
Zacks.com users have recently been watching Devon Energy (DVN) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
QUALCOMM Inc (NASDAQ: QCOM) reported third-quarter results at the end of last month that came in above analyst expectations, led by strength in automotive and IoT. Nakul Duggal, Qualcomm's senior vice president and general manager of automotive, dove deeper into what's driving the company's success in the automotive sector Monday on Benzinga's "Stock Market Movers" show. "The automotive industry is going through a transformation like never before," Duggal said. "Fundamentally what is happening i
This article discusses the top 10 stock picks of Carl Icahn’s Icahn Capital LP at the end of the second quarter. If you are short on time and already know about the fund’s history and recent performance, you can skip and go directly to Billionaire Carl Icahn’s Latest Portfolio: Top 5 Stock Picks. Barring Warren […]
Inflation, interest rates, and recession – these are the bogeymen of investing, and they’ve been watching over our shoulders for the past several months. We all know the story by now, the rate of inflation is running at generational highs, the Federal Reserve is hiking rates in an attempt to push back against high prices, and we’re in a technical recession after two quarters of negative GDP growth. At a time like this, investors are showing a growing interest in finding strong defensive portfoli
When it comes to investing greats, Berkshire Hathaway (NYSE: BRK.A)(NYSE: BRK.B) CEO Warren Buffett deserves to be in a class of his own. Although no investor is infallible, Warren Buffett's incredible track record speaks for itself. It's why everyone from Wall Street professionals to everyday investors waits on the edge of their seats to find out what the Oracle of Omaha has been buying, selling, and holding.
Yahoo Finance Live anchors break down Bed Bath & Beyond financing news that sent the stock higher on Monday.
In this article, we discuss 10 renewable energy stocks to buy and hold for the next 10 years. If you want to jump straight to the top stocks in this group, check out the 5 Best Renewable Energy Stocks to Buy and Hold for the Next 10 Years. The Inflation Reduction Act adds further certainty […]
Top trending stocks in after-hours trading.
Shares of Apple topped around $175 in the middle of August and turned lower – we hope traders took appropriate action. The trading volume does not appear to have increased on the late August decline but the On-Balance-Volume (OBV) line is pointing lower. In this weekly Japanese candlestick chart of AAPL, below, we can see a top reversal pattern in August looking at the candles.
Three steel stocks have formed valid bases and are in or near buy zones. However, views conflict on the steel market.
"I was actually happy to see how Chair Powell's Jackson Hole speech was received," Kashkari told Bloomberg's Odd Lots podcast. All three U.S stock benchmarks lost more than 3% on Friday after Powell told the annual central bankers conference in Jackson Hole, Wyoming, that the Fed would raise interest rates as high as needed to slow growth and soften the labor market.
The sale of the Fayetteville Shale assets brings ExxonMobil (XOM) closer to its goal of raising $15 billion from asset divestments to reduce debt and focus on low-cost oil production.
MELBOURNE (Reuters) -Woodside Energy Group Ltd more than tripled its interim dividend payout on Tuesday after the Australian gas producer posted a five-fold increase in first-half profit on booming oil and gas prices and its takeover of BHP Group's petroleum arm. Woodside has benefited from soaring liquefied natural gas (LNG) prices as sanctions on Russia after its invasion of Ukraine have forced gas buyers from Asia and Europe to seek alternative suppliers in what was already a tight market. Now among the world's top 10 independent oil and gas producers, Woodside announced an interim dividend of $1.09 per share, handing shareholders $2.1 billion, more than triple last year's payout and topping analysts' forecasts.
Yahoo Finance's Jared Blikre breaks down how markets are trading into the closing bell on Monday.

source

Share:

Pulse Handshak

Pulse Handshak

Collaborative online survey tool for the market research industry. Remote assisted surveying just like face-to-face interviews. Here interviewers can talk to the respondent over the web-console without the need for any other communication channel and share the same Q're with responses and click actions.

Pulse FE

Pulse FE

Pulse Field Expert or Pulse FE is the main platform for both offline and online survey at softofficepro.com. It is robust and used by hundreds of clients over tens of years with millions of responses. Do it once Q're and deploy on both offline devices (android) and online forms makes it a great cost effective platform for any kind of responses

Pulse Ultimate

Pulse Ultimate

Pulse Ultimate is targeted for tracking studies and retail audits. An offline survey system offering extreme field control including processes like data quality check, back-check, rework, comparison with previous wave data etc. helps to get the best results on a day-to-day basis

More Posts